Atlas Venture Life Science Advisors, LLC Dyne Therapeutics, Inc. Transaction History
Atlas Venture Life Science Advisors, LLC
- $341 Million
- Q1 2025
A detailed history of Atlas Venture Life Science Advisors, LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Atlas Venture Life Science Advisors, LLC holds 9,130,465 shares of DYN stock, worth $90.8 Million. This represents 27.97% of its overall portfolio holdings.
Number of Shares
9,130,465
Previous 8,019,354
13.86%
Holding current value
$90.8 Million
Previous $189 Million
49.45%
% of portfolio
27.97%
Previous 31.16%
Shares
6 transactions
Others Institutions Holding DYN
# of Institutions
217Shares Held
116MCall Options Held
322KPut Options Held
66.2K-
Janus Henderson Group PLC London, X010.4MShares$103 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$96.7 Million2.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.41MShares$73.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$73.5 Million0.01% of portfolio
-
Fcpm Iii Services B.V. Naarden, P75.46MShares$54.4 Million13.81% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $515M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...